TY - JOUR
T1 - Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments
T2 - The COBRA trial
AU - Banerjee, Subhash
AU - Das, Tony S.
AU - Abu-Fadel, Mazen S.
AU - Dippel, Eric J.
AU - Shammas, Nicolas W.
AU - Tran, Daniel L.
AU - Zankar, Ahmad
AU - Varghese, Cyril
AU - Kelly, Kevin C.
AU - Weideman, Rick A.
AU - Little, Bertis B.
AU - Reilly, Robert F.
AU - Addo, Tayo
AU - Brilakis, Emmanouil S.
N1 - Funding Information:
Dr. Banerjee receives research grants from Boston Scientific and The Medicines Company ; consultant/speaker honoraria from Gilead, St. Jude, Cordis, Boehringer Ingelheim, Sanofi, and Medtronic; is a consultant to Covidien; and has ownership in MDCARE GLOBAL (spouse) and intellectual property in HygeiaTel. Dr. Das is a member of the advisory board of Boston Scientific; and receives consultant/speaker honoraria from Abbott Vascular, Medtronic, and Terumo. Dr. Abu-Fadel receives consultant/speaker honoraria from Abbott Vascular. Dr. Dippel receives research grants from Covidien , eV3 , and Spectranetics ; consultant/speaker honoraria from Abbott Vascular, IDEV Technologies, Vessix Vascular, Spectranetics, Covidien, and WL Gore; and is a shareholder of Spectranetics. Dr. Shammas receives research grants from Boston Scientific , Cordis , and Abbott Vascular ; and is the Research Director of the Midwest Cardiovascular Research Foundation. Dr. Brilakis receives research grants from Abbott Vascular and Infraredex ; consultant/speaker honoraria from Terumo and St. Jude; and has employment link to Medtronic (spouse). Dr. Addo is a consultant to and receives speakers' fees from AstraZeneca. All other authors have reported they have no relationships relevant to the contents of this paper to disclose.
Funding Information:
Institutional grant support was provided by Boson Scientific Corporation .
PY - 2012/10/9
Y1 - 2012/10/9
N2 - Objectives: The purpose of this study is to compare post-dilation strategies of nitinol self-expanding stents implanted in the superficial femoral artery of diabetic patients with peripheral arterial disease. Background: Endovascular treatment of superficial femoral artery disease with nitinol self-expanding stents is associated with high rates of in-stent restenosis in patients with diabetes mellitus. Methods: We conducted a prospective, multicenter, randomized, controlled clinical trial of diabetic patients to investigate whether post-dilation of superficial femoral artery nitinol self-expanding stents using a cryoplasty balloon reduces restenosis compared to a conventional balloon. Inclusion criteria included diabetes mellitus, symptomatic peripheral arterial disease, and superficial femoral artery lesions requiring implantation of stents >5 mm in diameter and >60 mm in length. Primary endpoint was binary restenosis at 12 months, defined as <2.5-fold increase in peak systolic velocity by duplex ultrasonography. Results: Seventy-four patients, with 90 stented superficial femoral artery lesions, were randomly assigned to post-dilation using cryoplasty (n = 45 lesions) or conventional balloons (n = 45 lesions). Mean lesion length was 148 ± 98 mm, mean stented length was 190 ± 116 mm, mean stent diameter was 6.1 ± 0.4 mm, and 50% of the lesions were total occlusions. Post-dilation balloon diameters were 5.23 ± 0.51 mm versus 5.51 ± 0.72 mm in the cryoplasty and conventional balloon angioplasty groups, respectively (p = 0.02). At 12 months, binary restenosis was significantly lower in the cryoplasty group (29.3% vs. 55.8%, p = 0.01; odds ratio: 0.36, 95% confidence interval: 0.15 to 0.89). Conclusions: Among diabetic patients undergoing implantation of nitinol self-expanding stents in the superficial femoral artery, post-dilation with cryoplasty balloon reduced binary restenosis compared to conventional balloon angioplasty. (Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease [COBRA]; NCT00827853)
AB - Objectives: The purpose of this study is to compare post-dilation strategies of nitinol self-expanding stents implanted in the superficial femoral artery of diabetic patients with peripheral arterial disease. Background: Endovascular treatment of superficial femoral artery disease with nitinol self-expanding stents is associated with high rates of in-stent restenosis in patients with diabetes mellitus. Methods: We conducted a prospective, multicenter, randomized, controlled clinical trial of diabetic patients to investigate whether post-dilation of superficial femoral artery nitinol self-expanding stents using a cryoplasty balloon reduces restenosis compared to a conventional balloon. Inclusion criteria included diabetes mellitus, symptomatic peripheral arterial disease, and superficial femoral artery lesions requiring implantation of stents >5 mm in diameter and >60 mm in length. Primary endpoint was binary restenosis at 12 months, defined as <2.5-fold increase in peak systolic velocity by duplex ultrasonography. Results: Seventy-four patients, with 90 stented superficial femoral artery lesions, were randomly assigned to post-dilation using cryoplasty (n = 45 lesions) or conventional balloons (n = 45 lesions). Mean lesion length was 148 ± 98 mm, mean stented length was 190 ± 116 mm, mean stent diameter was 6.1 ± 0.4 mm, and 50% of the lesions were total occlusions. Post-dilation balloon diameters were 5.23 ± 0.51 mm versus 5.51 ± 0.72 mm in the cryoplasty and conventional balloon angioplasty groups, respectively (p = 0.02). At 12 months, binary restenosis was significantly lower in the cryoplasty group (29.3% vs. 55.8%, p = 0.01; odds ratio: 0.36, 95% confidence interval: 0.15 to 0.89). Conclusions: Among diabetic patients undergoing implantation of nitinol self-expanding stents in the superficial femoral artery, post-dilation with cryoplasty balloon reduced binary restenosis compared to conventional balloon angioplasty. (Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease [COBRA]; NCT00827853)
KW - cryoplasty
KW - diabetes mellitus
KW - peripheral arterial disease
KW - superficial femoral artery
UR - http://www.scopus.com/inward/record.url?scp=84867082929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867082929&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2012.05.042
DO - 10.1016/j.jacc.2012.05.042
M3 - Article
C2 - 22981558
AN - SCOPUS:84867082929
SN - 0735-1097
VL - 60
SP - 1352
EP - 1359
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 15
ER -